Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study.
CLARK, RA; Mukandavire, C; Portnoy, A; WEERASURIYA, CK; Deol, A; SCARPONI, D; Iskauskas, A; Bakker, R; Quaife, M; Malhotra, S; Gebreselassie, N; Zignol, M; Hutubessy, RC W; Giersing, B; JIT, M; Harris, RC; Menzies, NA; WHITE, RG;
2023
The Lancet. Global health, (2023).11 4 10.1016/s2214-109x(23)00045-1.
Is neglect of self-clearance biassing TB vaccine impact estimates?.
SCARPONI, D; CLARK, RA; Weerasuriya, C; EMERY, JC; HOUBEN, RM; WHITE, RG; MCCREESH, N;
2023
medRxiv (2023). 10.1101/2023.04.11.23288400.
Clinical trials of tuberculosis vaccines in the era of increased access to preventive antibiotic treatment.
Rangaka, MX; Frick, M; Churchyard, G; García-Basteiro, AL; Hatherill, M; Hanekom, W; Hill, PC; Hamada, Y; Quaife, M; Vekemans, J; WHITE, RG; Cobelens, F;
2023
The Lancet. Respiratory medicine, (2023).11 4 10.1016/s2213-2600(23)00084-x.
Demonstrating multi-country calibration of a tuberculosis model using new history matching and emulation package - hmer.
SCARPONI, D; Iskauskas, A; CLARK, RA; Vernon, I; McKinley, TJ; Goldstein, M; Mukandavire, C; Deol, A; Weerasuriya, C; Bakker, R; WHITE, RG; MCCREESH, N;
2023
Epidemics, (2023).43, 10.1016/j.epidem.2023.100678.
New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01 E and BCG-revaccination.
CLARK, RA; Weerasuriya, CK; Portnoy, A; Mukandavire, C; Quaife, M; Bakker, R; SCARPONI, D; Harris, RC; Rade, K; Mattoo, SK; Tumu, D; Menzies, NA; WHITE, RG;
2023
medRxiv (2023). 10.1101/2023.02.24.23286406.
Cost-effectiveness of tuberculosis infection prevention and control interventions in South African clinics: a model-based economic evaluation informed by complexity science methods.
BOZZANI, FM; MCCREESH, N; Diaconu, K; GOVENDER, I; WHITE, RG; Kielmann, K; GRANT, AD; VASSALL, A;
2023
BMJ Global Health, (2023).8 2 10.1136/bmjgh-2022-010306.
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.
Portnoy, A; CLARK, RA; Quaife, M; WEERASURIYA, CK; Mukandavire, C; Bakker, R; Deol, AK; Malhotra, S; Gebreselassie, N; Zignol, M; Sim, SY; Hutubessy, RC W; Baena, IG; Nishikiori, N; JIT, M; WHITE, RG; Menzies, NA;
2023
PLOS Medicine, (2023).20 1 10.1371/journal.pmed.1004155.
Impact, cost-effectiveness, and budget implications of HPV vaccination in Kenya: A modelling study.
Mwenda, V; Jalang'o, R; Miano, C; Bor, J-P; Nyangasi, M; Mecca, L; Were, V; Kariithi, E; Pecenka, C; Schuind, A; ABBAS, K; CLARK, A;
2023
Vaccine, (2023).41 29 10.1016/j.vaccine.2023.05.019.
Modeling the potential health impact of prospective Strep A vaccines.
Giannini, F; Cannon, JW; Cadarette, D; Bloom, DE; Moore, HC; Carapetis, J; ABBAS, K;
2023
NPJ vaccines, (2023).8 1 10.1038/s41541-023-00668-0.
Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study.
KIM, C; Holm, M; Frost, I; Hasso-Agopsowicz, M; ABBAS, K;
2023
BMJ global health, (2023).8 7 10.1136/bmjgh-2022-011341.